Concentra Earnings Call Highlights Growth, Rising Confidence

Concentra Group Holdings Parent, Inc. ((CON)) has held its Q1 earnings call. Read on for the main highlights of the call.

Concentra Group Holdings Parent, Inc. opened 2026 with a broadly upbeat tone, highlighting double‑digit revenue growth, stronger margins, and sharply better free cash flow. Management emphasized that integration of recent acquisitions is running ahead of schedule and that upgraded 2026 guidance reflects growing confidence, even as they acknowledged leverage, G&A inflation, and slower employer services as watch points.

Revenue Growth — Strong Start to 2026

Concentra reported Q1 2026 revenue of $569.6 million, up 13.7% from $500.8 million a year earlier, marking a robust start to the year. Even excluding contributions from Nova and Pivot, revenue rose to $520.3 million, a 6.3% year‑over‑year increase that points to solid underlying organic momentum.

Visit Volume Expansion

Patient throughput continued to climb, with total visits up 6.7% to more than 54,000 per day, underscoring strong demand for the company’s services. Workers’ compensation visits per day jumped 9.6% and employer services visits rose 4.8%, while excluding Nova, total visits advanced 2.9%, led by a 6.2% gain in workers’ comp.

Revenue per Visit and Mix Improvement

Average revenue per visit improved roughly 3.1% year‑over‑year, helped by favorable rate and mix dynamics in the portfolio. Workers’ compensation revenue per visit increased from $209 to $213 and employer services rose from $94 to $97, signaling steady pricing and an improved case mix.

Adjusted EBITDA and Margin Expansion

Profitability moved higher as adjusted EBITDA reached $120.7 million in Q1 2026, up 17.6% from $102.7 million in the prior‑year quarter. Adjusted EBITDA margin expanded by 69 basis points to 21.2%, and trailing twelve‑month adjusted EBITDA climbed to $450 million, a 23% gain from the IPO baseline.

Adjusted Net Income and EPS Growth

Earnings leveraged the top‑line and margin gains, with adjusted net income attributable to the company rising to $51.5 million from $42.2 million. Adjusted EPS increased to $0.40 from $0.33, underscoring stronger per‑share profitability as operating efficiencies and higher volumes flowed through the income statement.

On‑Site Health Clinics — Rapid Expansion

On‑site health clinics emerged as a standout growth engine, generating $37.2 million in revenue in Q1 2026, a 125% jump versus a year ago, largely due to the Pivot acquisition. Even without Pivot, on‑site revenue grew 20.9%, and the run‑rate is approaching $150 million, more than doubling from $64 million in 2024 and signaling a rapidly scaling business line.

Successful M&A Integration and Synergies

Management highlighted that the March 2025 integration of Nova is complete and running ahead of plan, putting the transaction on track for a multiple below 7.5 times adjusted EBITDA. The June 2025 integration of Pivot is also ahead of expectations, with synergies pointing to a transaction multiple under 9 times, reinforcing the strategic and financial logic of recent deals.

Improved Cash Flow and Strengthened Guidance

Cash generation improved markedly as operating cash flow rose to $21.0 million from $11.7 million in the prior year, while free cash flow swung to $9.9 million from negative $4.0 million. On this momentum, the company lifted 2026 guidance for revenue, adjusted EBITDA, and free cash flow, signaling confidence in sustained growth and expanding profitability.

Cost of Services and Center Efficiency Gains

Cost discipline at the center level contributed to margin gains, with cost of services falling to 70.1% of revenue from 71.3% a year earlier. Management credited staffing efficiencies and improved center‑level margins for the improvement, suggesting that operational optimization is becoming a durable earnings lever.

Capital Deployment and Shareholder Returns

The company continued to return cash to investors while managing its balance sheet, repurchasing about 661,000 shares for $15 million and paying $8 million in dividends during the quarter. It ended Q1 with $61.7 million of cash and $1.58 billion of total debt, resulting in net leverage of 3.4 times, with management targeting a sub‑3 times level by year‑end.

Employer Services Growth Lagging

Despite overall revenue gains, employer services lagged workers’ compensation, underscoring an area of relative softness in the portfolio. Employer services revenue grew 7.6% in total but only 3.2% excluding Nova, with visits per day up just 0.7% on an organic basis and the segment remaining sensitive to slower hiring trends in the broader economy.

Higher Adjusted G&A as Percentage of Revenue

General and administrative costs rose faster than sales, with total G&A reaching $55.3 million, or 9.7% of revenue, versus 9.3% a year earlier. Adjusted G&A, at $50.2 million or 8.8% of revenue, climbed from 8.2%, reflecting planned hiring and IT investments tied to the company’s ongoing separation from its former parent.

Debt Level and Leverage Risk

Leverage remains elevated at $1.58 billion of total debt and net leverage of 3.4 times, making balance‑sheet de‑risking a key focus for management and investors alike. While leadership reiterated expectations to reduce net leverage below 3 times by year‑end, they acknowledged that current debt levels warrant continued monitoring.

Rate Timing and Mix Effects on Revenue per Visit

Reimbursement dynamics presented both support and complexity, with a California workers’ compensation rate change only benefiting one month of the quarter due to its March 1 effective date. That timing, along with visit mix, limited the realized rate uplift to a 2% increase in workers’ comp revenue per visit, and uncertainty persists around the timing of other state adjustments.

Separation and Investment Costs

The ongoing separation from Select required incremental hiring and technology milestones, creating temporary cost pressure even as the process nears completion. Management noted that about 95% of required full‑time employees have been hired, and they expect separation‑related investments to taper once the November 2026 functional deadline is met.

Seasonality and Q1 Cash Flow Mix

Seasonal patterns continued to influence results, with Q1 typically the lowest free cash flow quarter due to working capital dynamics and planned capital expenditures. While year‑over‑year free cash flow improved, management reminded investors that cash conversion will remain uneven near term, with full‑year CapEx still expected in the $70 million to $80 million range.

Forward‑Looking Guidance and Outlook

Looking ahead, management raised 2026 revenue guidance to a range of $2.275 billion to $2.375 billion and lifted adjusted EBITDA expectations to $460 million to $480 million, reflecting confidence in sustained demand and efficiency gains. Free cash flow guidance was also increased to $215 million to $235 million, net leverage is projected comfortably below 3 times, and the company plans to balance capital returns via dividends and buybacks with continued investment in growth.

Concentra’s latest earnings call painted a picture of a company executing well on both growth and integration, with rising volumes, expanding margins, and improving cash flow underpinning upgraded guidance. While leverage, G&A inflation, and softer employer services remain important watch factors, the trajectory of core workers’ compensation, on‑site clinics, and M&A synergies suggests a constructive setup for investors tracking the story.